Report : A-Z CDF items in Formulary 26/02/2021 13:05:20

[Back]

Section Status CDF Name 08.01.05 Formulary Abemaciclib tabs  08.01.05 Formulary Atezolizumab injection urothelial cancer indications 08.01.05 Formulary Avelumab injection  renal cell carcinoma 08.01.05 Formulary Avelumab injection   08.01.05 Formulary Axicabtagene ciloleucel cells dispersion for infusion  08.01.01 Formulary Bendamustine injection  08.01.05 Formulary Bevacizumab injection licensed use 08.01.05 Formulary Bortezomib injection  08.01.05 Formulary Cemiplimab injection   08.01.05 Formulary Crizotinib caps  08.02.04 Formulary Daratumumab injection  08.01.05 Formulary Durvalumab injection  08.01.05 Formulary Entrectinib caps  08.03.04.01 Formulary Fulvestrant injection  08.01.05 Formulary Ibrutinib caps  08.01.05 Formulary Ipilimumab injection  08.02.04 Formulary Ixazomib caps  08.01.05 Formulary Larotrectinib oral solution  08.01.05 Formulary Niraparib caps  08.01.05 Formulary Nivolumab injection haematological and lung cancer 08.01.05 Formulary Nivolumab injection head and neck, renal and skin cancer 08.02.03 Formulary Obinutuzumab injection  08.01.05 Formulary Olaparib tabs  08.01.05 Formulary Palbociclib tabs  08.01.05 Formulary Pembrolizumab injection lymphoma and lung cancer indications 08.01.05 Formulary Pembrolizumab injection urothelial cancer indications 08.02.04 Formulary Pomalidomide caps  08.01.05 Formulary Ribociclib tabs  08.01.05 Formulary Rucaparib tabs  08.01.05 Formulary Tisagenlecleucel cells dispersion for infusion  08.01.05 Formulary Venetoclax tabs

South East London Joint Medicines Formulary